McMaster Textbook of Internal Medicine

McMaster Textbook of Internal Medicine
Interviews
Cardiology
Control of uric acid as part of cardiovascular disease prevention

Control of uric acid as part of cardiovascular disease prevention

2018-11-16

Gerd Hasenfuß

Recorded at the 4th McMaster International Review Course in Internal Medicine (MIRCIM).

Is it currently recommended to measure the uric acid level in blood and reduce it pharmacologically as part of cardiovascular disease prevention?

Gerd Hasenfuß, MD: In epidemiological studies it has been shown to be a risk factor for coronary artery disease, but there is no data showing that reduction of uric acid levels reduces cardiovascular risk. Currently, there is no recommendation to use these drugs with the purpose of reducing cardiovascular risk. Of course, if there is gout or some other symptoms, then it is needed, but not to reduce cardiovascular risk. That is also true for heart failure patients in particular.

See also

Secondary prevention of cardiovascular diseases: current state-of-art A lecture by Dr Gerd Hasenfuß, from the University of Göttingen, Germany, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
Adjusting exercise in patients with heart failure How to adjust the level of exercise in a patient with heart failure?
Management of chronic heart failure: what should we change in our practice A lecture by Dr Piotr Ponikowski, from Wroclaw Medical University, Poland, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Cardiac rehabilitation after MI Which patients after myocardial infarction (MI) qualify for cardiac rehabilitation? When should it be started and what should it involve?
New approach to perioperative cardiovascular care: a task for internists A lecture by Dr P.J. Devereaux, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Antihypertensive treatment in young patients with mildly elevated BP Should antihypertensive treatment be introduced in young patients with a mildly elevated systolic or diastolic blood pressure?
Invasive treatment in STEMI: PCI of the culprit vessel vs a multivessel approach Which invasive treatment strategy is preferred in ST-segment elevation myocardial infarction (STEMI): PCI of the infarct-related artery only or revascularization of all significant lesions?
Hypertension in the elderly and universal BP targets Dr Franz H. Messerli discusses treatment of hypertension in the elderly patients, the idea of setting universal blood pressure targets, and the results of SPRINT in a conversation with Dr Jerzy Gąsowski.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.